BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37984711)

  • 1. Dose-Volume Predictors of Radiation Pneumonitis After Thoracic Hypofractionated Radiation Therapy.
    Sasse A; Oh P; Saeed N; Yang DX; Hayman TJ; Knowlton CA; Peters GW; Campbell A; Laird J; Housri N; Park HS
    Pract Radiat Oncol; 2024; 14(2):e97-e104. PubMed ID: 37984711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary dose tolerance in hemithorax radiotherapy for Ewing sarcoma of the chest wall: Are we overestimating the risk of radiation pneumonitis?
    Parekh AD; Indelicato DJ; Hoppe BS; Vega RBM; Rotondo RL; Bradley JA
    Pediatr Blood Cancer; 2021 Nov; 68(11):e29287. PubMed ID: 34398486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
    Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis.
    Bi J; Meng R; Yang D; Li Y; Cai J; Zhang L; Qian J; Xue X; Hu S; Yuan Z; Verma V; Bi N; Han G
    Radiother Oncol; 2024 Jan; 190():110040. PubMed ID: 38042497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging.
    Lee HJ; Zeng J; Vesselle HJ; Patel SA; Rengan R; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1255-1264. PubMed ID: 30108002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry.
    Dhami G; Zeng J; Vesselle HJ; Kinahan PE; Miyaoka RS; Patel SA; Rengan R; Bowen SR
    Strahlenther Onkol; 2017 May; 193(5):410-418. PubMed ID: 28255667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors.
    Bi J; Qian J; Yang D; Sun L; Lin S; Li Y; Xue X; Nie T; Verma V; Han G
    Front Immunol; 2021; 12():828858. PubMed ID: 35095930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
    Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy.
    Chen F; Niu J; Wang M; Zhu H; Guo Z
    Radiat Oncol; 2024 May; 19(1):67. PubMed ID: 38816745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs.
    Bongers EM; Botticella A; Palma DA; Haasbeek CJ; Warner A; Verbakel WF; Slotman B; Ricardi U; Senan S
    Radiother Oncol; 2013 Oct; 109(1):95-9. PubMed ID: 24183862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy.
    Agrawal S; Kumar S; Lawrence A; Das MK; Kumar S
    South Asian J Cancer; 2014 Jan; 3(1):13-5. PubMed ID: 24665439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
    Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations Between Mean Lung Dose and Prevalence of Radiation Pneumonitis in Elderly Lung Cancer Patients.
    Rades D; Cremers F; Janssen S; Bartscht T; Kristiansen C; Timke C; Duma MN; Yu NY; Bohnet S
    Anticancer Res; 2024 May; 44(5):2073-2079. PubMed ID: 38677766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer.
    Kim M; Lee J; Ha B; Lee R; Lee KJ; Suh HS
    Radiat Oncol J; 2011 Sep; 29(3):181-90. PubMed ID: 22984669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
    Allen AM; Czerminska M; Jänne PA; Sugarbaker DJ; Bueno R; Harris JR; Court L; Baldini EH
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):640-5. PubMed ID: 16751058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.
    Harder EM; Park HS; Chen ZJ; Decker RH
    Pract Radiat Oncol; 2016; 6(6):e353-e359. PubMed ID: 27156424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
    Kim TH; Cho KH; Pyo HR; Lee JS; Zo JI; Lee DH; Lee JM; Kim HY; Hwangbo B; Park SY; Kim JY; Shin KH; Kim DY
    Radiology; 2005 Apr; 235(1):208-15. PubMed ID: 15703313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab.
    Diamond BH; Belani N; Masel R; DeCarli K; DiPetrillo T; Hepel JT; Azzoli CG; Khurshid H; Abbas A; Koffer PP
    Adv Radiat Oncol; 2023; 8(2):101130. PubMed ID: 36845618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
    Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.